Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluconazole for refractory acute exacerbation of chronic obstructive pulmonary disease
ChiCTR1900025535Phase 4Not yet recruiting
- Sponsor
- Guangzhou First People's Hospital
- Start
- Oct 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of fluconazole in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Guangzhou First People's Hospital. Primary endpoint: Length of stay in hospital. Planned start Oct 2019; status: not yet recruiting.
02
Drugs
fluconazole
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR1900025535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025535.